Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
Clinical trial NCT02870205 · COMPLETED
Trial details
- NCT number
- NCT02870205
- Sponsor
- Glenmark Specialty S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-01-01
- Enrollment
- 1176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.